Forte Biosciences, Inc.
FBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $22 | $12 | $41 | $42 |
| Short-Term Investments | $36 | $25 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $1 | $0 | $0 |
| Total Curr. Assets | $61 | $38 | $42 | $43 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 | $1 |
| Total NC Assets | $0 | $1 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $62 | $39 | $42 | $43 |
| Liabilities | – | – | – | – |
| Payables | $5 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $2 | $2 | $1 |
| Total Curr. Liab. | $9 | $4 | $3 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9 | $4 | $3 | $2 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $43 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$154 | -$119 | -$87 | -$73 |
| AOCI | $0 | $0 | $0 | -$43 |
| Other Equity | $206 | $154 | $126 | $115 |
| Total Equity | $52 | $35 | $39 | $42 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $62 | $39 | $42 | $43 |
| Net Debt | -$22 | -$12 | -$41 | -$42 |